Radiofrequency vapor ablation delivered through an endoscope working channel. The system is cleared for GI tract ablation, and the company is testing a duodenal mucosal ablation procedure for type 2 diabetes under an FDA IDE.
One email, every morning
THE MORNING BRIEF
New clearances, funding rounds and regulatory moves for device founders, and every new how-to guide and template as it lands. No noise, no login.
✓
You're in. The next morning brief lands in your inbox.
Unsubscribe anytime. We never sell the list.
By registering, you agree to receive communications from us. Your information may also be shared with sponsors and partners identified on this Site for relevant industry communications. You may unsubscribe at any time. See our Privacy Policy.